These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16564944)

  • 21. Economic evaluation of dialysis therapies.
    Klarenbach S; Manns B
    Semin Nephrol; 2009 Sep; 29(5):524-32. PubMed ID: 19751898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls.
    Roach JL; Turenne MN; Hirth RA; Wheeler JR; Sleeman KS; Messana JM
    Am J Kidney Dis; 2010 Nov; 56(5):928-36. PubMed ID: 20888100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The costs of dialysis in Canada.
    Prichard SS
    Nephrol Dial Transplant; 1997; 12 Suppl 1():22-4. PubMed ID: 9075224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost of clinical dialysis--a historical perspective.
    Attrill E; Johnson HK
    Semin Nephrol; 2000 Nov; 20(6):523-5. PubMed ID: 11111853
    [No Abstract]   [Full Text] [Related]  

  • 28. Dissecting the bundle: The final rules for the prospective payment system for dialysis.
    Mayne T
    Nephrol News Issues; 2010 Sep; 24(10):14, 16, 18-9. PubMed ID: 20942326
    [No Abstract]   [Full Text] [Related]  

  • 29. What price success?
    Tecnologica; 1996 Nov; ():1-6. PubMed ID: 10179816
    [No Abstract]   [Full Text] [Related]  

  • 30. A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies.
    Lee CP; Chertow GM; Zenios SA
    Med Decis Making; 2006; 26(5):535-49. PubMed ID: 16997929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The costs of dialysis treatments for patients with end-stage renal disease in France.
    Jacobs C
    Nephrol Dial Transplant; 1997; 12 Suppl 1():29-32. PubMed ID: 9075226
    [No Abstract]   [Full Text] [Related]  

  • 32. The ESRD bundle creates a perfect storm.
    Crafton D
    Nephrol News Issues; 2010 Jul; 24(8):36, 38. PubMed ID: 20695321
    [No Abstract]   [Full Text] [Related]  

  • 33. Kidney Failure? Dialysis is the only medical service without automatic inflation updates from Medicare. Some people are trying to change that.
    Zigmond J
    Mod Healthc; 2006 Nov; 36(44):6-7, 14-6, 1. PubMed ID: 17128943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost of hemodialysis in Iran.
    Arefzadeh A; Lessanpezeshki M; Seifi S
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can end-stage renal disease be delayed?
    Naper J
    Hosp Technol Ser; 1994 Dec; 13(15):5-7. PubMed ID: 10139506
    [No Abstract]   [Full Text] [Related]  

  • 36. End-stage renal diseases in patients 75 and over: a new medical, socio-economical and ethical challenge.
    Mignon F; Michel C; Viron B; Mentre F; Jaar B
    Eur J Med; 1992 Sep; 1(5):302-7. PubMed ID: 1341612
    [No Abstract]   [Full Text] [Related]  

  • 37. Patient activation status as a predictor of patient experience among Medicare beneficiaries.
    Heller A; Elliott MN; Haviland AM; Klein DJ; Kanouse DE
    Med Care; 2009 Aug; 47(8):850-7. PubMed ID: 19584763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs.
    Lacson E; Ikizler TA; Lazarus JM; Teng M; Hakim RM
    J Ren Nutr; 2007 Nov; 17(6):363-71. PubMed ID: 17971308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.